Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The price of Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) closed at $8.05 in the last session, up 0.88% from day before closing price of $7.98. In other words, the price has increased by $0.88 from its previous closing price. On the day, 3.48 million shares were traded. BCRX stock price reached its highest trading level at $8.12 during the session, while it also had its lowest trading level at $7.94.
Ratios:
We take a closer look at BCRX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.58 and its Current Ratio is at 2.63.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wedbush on February 25, 2025, initiated with a Outperform rating and assigned the stock a target price of $15.
RBC Capital Mkts Upgraded its Sector Perform to Outperform on September 18, 2023, whereas the target price for the stock was revised from $9 to $10.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 13 ’24 when Hutson Nancy J sold 7,000 shares for $7.54 per share. The transaction valued at 52,780 led to the insider holds 86,638 shares of the business.
Hutson Nancy J bought 7,000 shares of BCRX for $52,584 on Dec 13 ’24. On Jun 24 ’24, another insider, McKee Amy E, who serves as the Director of the company, sold 8,600 shares for $6.32 each. As a result, the insider received 54,352 and left with 27,831 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCRX now has a Market Capitalization of 1682128000 and an Enterprise Value of 2202696192. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.73. Its current Enterprise Value per Revenue stands at 4.887 whereas that against EBITDA is 1271.031.
Stock Price History:
The Beta on a monthly basis for BCRX is 1.73, which has changed by 0.6067864 over the last 52 weeks, in comparison to a change of 0.10838497 over the same period for the S&P500. Over the past 52 weeks, BCRX has reached a high of $9.50, while it has fallen to a 52-week low of $4.03. The 50-Day Moving Average of the stock is -0.70%, while the 200-Day Moving Average is calculated to be 5.64%.
Shares Statistics:
According to the various share statistics, BCRX traded on average about 3.13M shares per day over the past 3-months and 3393800 shares per day over the past 10 days. A total of 208.54M shares are outstanding, with a floating share count of 197.24M. Insiders hold about 5.61% of the company’s shares, while institutions hold 78.44% stake in the company. Shares short for BCRX as of 1740700800 were 16007226 with a Short Ratio of 5.12, compared to 1738281600 on 17305378. Therefore, it implies a Short% of Shares Outstanding of 16007226 and a Short% of Float of 7.7199996.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
